Vicki L. Sato - 30 Jul 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 17:37:11 UTC
Previous filing
23 Jul 2021
Next filing
20 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +19,362 $0.000000 19,362 30 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +31,692 $0.000000 31,692 30 Jul 2021 Common Stock 31,692 $21.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest in a series of 36 successive equal monthly installments measured from the date of grant.